biostudies-literatureUnknown15(6)Basso-Valentina FAssociazione Italiana per la Ricerca sul CancroMinistero dell'Università e della RicercaMinistero della SaluteAlleanza Contro il CancroMinistero dell'Università e della RicercaClinical and translational medicinee70373https://www.ebi.ac.uk/biostudies/studies/S-EPMC12183328biostudies-literatureProgrammed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study.PMC12183328CO‐2018‐12367051Italy Post-Doc Fellowship 29639PNRR-MAD-2022-12375663Italy Post‐Doc Fellowship 31335RCR‐2022‐23682287CO-2018-12367051IG 26253Italy Post-Doc Fellowship 31335PNRR‐MAD‐2022‐12375663ARS01_00568RCR-2022-23682287RicercacorrenteL1andL3/13IG 25932Italy Post‐Doc Fellowship 29639Canzonieri VRusso DPerrone FDi Mauro APignata SSalutari VLorusso DCinieri SCecere SCChiodini PPivetta EBaldassarre GDe Angelis CCalifano DArtioli GScognamiglio GArenare LDe Cecio RBasso-Valentina FSpina AfalseProgrammed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study.2025-01-01T00:00:00Z2025 Jun2026-06-03T07:10:48.583Z2026-04-25T03:22:41.147ZS-EPMC121833284054572510.1002/ctm2.70373